Indivior | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AstraZeneca USD 41.04B 168M 2025-03
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Halozyme Therapeutics USD 482.27M 118.45M 2025-03
Indivior -285000000 63M 2025-03
J&J USD 78.11B 6.62B 2025-03
Kyowa Hakko Kirin JPY 831.42B 19.39B 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Sanofi 77.86B 4.86B 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12



Indivior Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.